Suppr超能文献

表皮JB6细胞中蛋白激酶C的肿瘤促进作用及消耗

Tumor promotion and depletion of protein kinase C in epidermal JB6 cells.

作者信息

Kischel T, Harbers M, Stabel S, Borowski P, Müller K, Hilz H

机构信息

Institut für Physiologische Chemie, Universität Hamburg, Germany.

出版信息

Biochem Biophys Res Commun. 1989 Dec 29;165(3):981-7. doi: 10.1016/0006-291x(89)92699-5.

Abstract

Promotion of JB6 epidermal cells to anchorage-independent growth requires exposure to TPA for greater than 4 days. Over a similar time span, a practically complete loss of enzymic and immunoreactive proteinkinase C (PKC) equivalents was observed at greater than 10 nM TPA. Promotion did not appear to require (transient) activation of PKC since PKC inhibitors H7 and HA1004 did not prevent but enhanced colony formation in soft agar at concentrations greater than IC50-values. The efficacy of the inhibitors in vivo was shown by their ability to suppress PKC-induced transcription of c-fos gen. PKC inhibitors that interfered with cell proliferation at lower concentrations than those required for PKC inhibition (sphingosine, staurosporin, sangivamycin, trifluoperazine) did not stimulate anchorage-independent growth. As H7 as well as HA1004 were able to promote JB6 cells in the complete absence of TPA, and induced neither depletion nor processing of PKC we postulate that depletion/inactivation rather than activation of PKC correlates with the promotion of epidermal JB6 cells to anchorage-independent growth.

摘要

促进JB6表皮细胞进行不依赖贴壁的生长需要使其暴露于佛波酯(TPA)超过4天。在相似的时间段内,当TPA浓度高于10 nM时,可观察到酶活性和免疫反应性蛋白激酶C(PKC)等效物几乎完全丧失。促进作用似乎并不需要(短暂)激活PKC,因为PKC抑制剂H7和HA1004在浓度高于半数抑制浓度(IC50)时,并不会阻止而是增强软琼脂中的集落形成。抑制剂在体内的效力通过其抑制PKC诱导的c-fos基因转录的能力得以体现。在低于抑制PKC所需浓度时就干扰细胞增殖的PKC抑制剂(鞘氨醇、星形孢菌素、链黑菌素、三氟拉嗪)并不会刺激不依赖贴壁的生长。由于H7以及HA1004能够在完全不存在TPA的情况下促进JB6细胞生长,且既不诱导PKC的消耗也不诱导其加工处理,因此我们推测PKC的消耗/失活而非激活与表皮JB6细胞向不依赖贴壁生长的促进作用相关。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验